Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × ibrutinib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22 Lymphoma, Mantle-Cell 8 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 5 Waldenstrom Macroglobulinemia 4 Lymphoma, Follicular 3 Leukemia 3 Recurrence 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Lymphoid 2 Leukemia, Hairy Cell 2 Leukemia, B-Cell 2 Hematologic Diseases 2 Burkitt Lymphoma 2 Bronchiolitis Obliterans Syndrome 2 Primary Central Nervous System Lymphoma (PCNSL) 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Plasma Cell 1 Melanoma 1 Medulloblastoma 1 Lymphoma, B-Cell 1 Glioblastoma 1 Ependymoma 1 Chromosome 17 deletion 1 Brain Neoplasms 1 Bone Marrow Diseases 1

Interventions

Magnetic Resonance Spectroscopy 5 Biopsy 4 X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 selpercatinib 2 erdafitinib 2 entrectinib 2 ensartinib 2 Radiotherapy 2 Nivolumab 2 Lomustine 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 regorafenib 1 perillyl alcohol 1 pemigatinib 1 pembrolizumab 1 pegfilgrastim 1 palbociclib 1 olaparib 1 niraparib 1 lenvatinib 1 larotrectinib 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡